Leland W.K. Chung
Hong Kong Polytechnic University(HK)National University of Singapore(SG)Palo Alto University(US)Georgetown University(US)VA Palo Alto Health Care System(US)Georgetown University Medical Center(US)Stanford Health Care(US)WisdomTools (United States)(US)Stanford Medicine(US)Royal Darwin Hospital(AU)University of California Davis Medical Center(US)University of California, Davis(US)Stanford University(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Systemic Sclerosis and Related Diseases, Inflammatory Myopathies and Dermatomyositis, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Bone health and treatments
Most-Cited Works
- → In vivo cancer targeting and imaging with semiconductor quantum dots(2004)4,715 cited
- → 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative(2013)3,340 cited
- Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.(1992)
- Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.(1994)
- → Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial(2016)656 cited
- → Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers(2011)617 cited
- → The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study(2011)